In this webcast, experts discuss clinical trial data from DEFINE-FLAIR and iFR-SWEDEHEART that were presented at the American College of Cardiology (ACC) 2017 meeting as well as the implications and benefits of iFR and the future of physiologic guidance. 

For more information, please visit www.volcanocorp.com/clinical/iFR

PANEL (Left to Right):

Justin Davies, MD, PhD
Imperial College London

Matthias Götberg, MD, PhD
Skåne University Hospital

Habib Samady, MD
Emory University Hospital

Gregg Stone, MD (Moderator)
Columbia University Medical Center